GARY GOLDMAN

Gary Goldman is a distinguished Managing Director at the Global Health Impact Fund, a leading organization committed to fostering innovation and driving positive change within the global healthcare landscape. In his pivotal role, Gary is instrumental in identifying, evaluating, and executing strategic investments that align with the fund's dual mandate of achieving robust financial performance and generating measurable health impact across the globe.

At the Global Health Impact Fund, Gary's investment focus areas are broad yet deeply specialized, encompassing a range of sectors critical to advancing global health. These include biotechnology, with an emphasis on novel therapeutics and diagnostics for underserved populations; medical technology, particularly devices and platforms that improve access and affordability; digital health solutions, leveraging technology to enhance care delivery and patient engagement; and public health initiatives, supporting ventures that address systemic health disparities and improve health infrastructure in developing regions. His expertise lies in recognizing disruptive innovations that have the potential for widespread adoption and significant societal benefit.

Gary's extensive career background reflects a deep commitment to healthcare investment and a proven track record of success. Prior to joining the Global Health Impact Fund, he held senior positions at prominent venture capital firms and private equity groups specializing in life sciences and healthcare. His experience includes leading investment rounds, serving on numerous company boards, and guiding portfolio companies through critical growth stages, from early-stage development to market entry and expansion. This background has equipped him with a comprehensive understanding of the healthcare ecosystem, from scientific research and development to regulatory pathways and market commercialization.

While specific notable investments are proprietary to the fund, Gary has been a key architect in backing companies that have gone on to achieve significant milestones. These include firms developing affordable vaccines for infectious diseases, innovative diagnostic tools for early disease detection in low-resource settings, and digital platforms that connect patients in remote areas with specialized medical care. His strategic vision and deep industry knowledge enable him to identify opportunities that not only promise strong financial returns but also contribute meaningfully to global health equity and access. Gary Goldman's leadership at the Global Health Impact Fund underscores his dedication to leveraging capital for a healthier, more equitable world.